Product
DTaP-IPV
2 clinical trials
5 indications
Indication
Pneumococcal InfectionsIndication
DiphtheriaIndication
TetanusIndication
PertussisIndication
PoliomyelitisClinical trial
A Phase I, Double-Blind, Randomized, Multicenter Trial of the Safety,Tolerability, and Immunogenicity of V114 in Healthy Japanese InfantsStatus: Completed, Estimated PCD: 2020-06-24